These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28628723)

  • 1. A Multifunctional Radiotheranostic Agent for Dual Targeting of Breast Cancer Cells.
    Vultos F; Fernandes C; Mendes F; Marques F; Correia JDG; Santos I; Gano L
    ChemMedChem; 2017 Jul; 12(14):1103-1107. PubMed ID: 28628723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of chelate conjugation on a newly identified tumor-targeting peptide.
    Mier W; Zitzmann S; Krämer S; Reed J; Knapp EM; Altmann A; Eisenhut M; Haberkorn U
    J Nucl Med; 2007 Sep; 48(9):1545-52. PubMed ID: 17704241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.
    Boswell CA; Sun X; Niu W; Weisman GR; Wong EH; Rheingold AL; Anderson CJ
    J Med Chem; 2004 Mar; 47(6):1465-74. PubMed ID: 14998334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel chemically modified analogues of neuropeptide Y for tumor targeting.
    Zwanziger D; Khan IU; Neundorf I; Sieger S; Lehmann L; Friebe M; Dinkelborg L; Beck-Sickinger AG
    Bioconjug Chem; 2008 Jul; 19(7):1430-8. PubMed ID: 18572959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and stability of the [
    Roy T; Pogorilyy E; Kumarananthan CP; Kvitastein UA; Foscato M; Törnroos KW; Adamsen TCH; Le Roux E
    Chem Commun (Camb); 2024 Jul; 60(56):7148-7151. PubMed ID: 38860653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of new derivatives of 1,3-diazaheterocycles.
    Krezel I
    Pharmazie; 1998 Sep; 53(9):614-7. PubMed ID: 9770209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new biotin derivative-DOTA conjugate as a candidate for pretargeted diagnosis and therapy of tumors.
    Sabatino G; Chinol M; Paganelli G; Papi S; Chelli M; Leone G; Papini AM; De Luca A; Ginanneschi M
    J Med Chem; 2003 Jul; 46(14):3170-3. PubMed ID: 12825956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of functionalised HP-DO3A chelating agents for conjugation to biomolecules.
    Barge A; Cappelletti E; Cravotto G; Ferrigato A; Lattuada L; Marinoni F; Tei L
    Org Biomol Chem; 2009 Sep; 7(18):3810-6. PubMed ID: 19707687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of intercalating somatostatin receptor binding peptide conjugates for endoradiotherapy.
    Graham K; Wang Q; Garcia Boy R; Eisenhut M; Haberkorn U; Mier W
    J Pharm Pharm Sci; 2007; 10(2):286s-297s. PubMed ID: 17718932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro evaluation of an 111In-labeled ST-peptide enterotoxin (ST) analogue for specific targeting of guanylin receptors on human colonic cancers.
    Gali H; Sieckman GL; Hoffman TJ; Kiefer GE; Chin DT; Forte LR; Volkert WA
    Anticancer Res; 2001; 21(4A):2785-92. PubMed ID: 11724355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facile synthesis and evaluation of C-functionalized benzyl-1-oxa-4,7,10-triazacyclododecane-N,N',N″-triacetic acid as chelating agent for ¹¹¹In-labeled polypeptides.
    Suzuki H; Kanai A; Uehara T; Guerra Gomez FL; Hanaoka H; Arano Y
    Bioorg Med Chem; 2012 Jan; 20(2):978-84. PubMed ID: 22178661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.
    Dijkgraaf I; Liu S; Kruijtzer JA; Soede AC; Oyen WJ; Liskamp RM; Corstens FH; Boerman OC
    Nucl Med Biol; 2007 Jan; 34(1):29-35. PubMed ID: 17210459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene.
    Gallazzi F; Wang Y; Jia F; Shenoy N; Landon LA; Hannink M; Lever SZ; Lewis MR
    Bioconjug Chem; 2003; 14(6):1083-95. PubMed ID: 14624621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of DOTA chelator position on biodistribution and targeting properties of (111)In-labeled synthetic anti-HER2 affibody molecules.
    Perols A; Honarvar H; Strand J; Selvaraju R; Orlova A; Karlström AE; Tolmachev V
    Bioconjug Chem; 2012 Aug; 23(8):1661-70. PubMed ID: 22768790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel heterobimetallic radiotheranostic: preparation, activity, and biodistribution.
    Adriaenssens L; Liu Q; Chaux-Picquet F; Tasan S; Picquet M; Denat F; Le Gendre P; Marques F; Fernandes C; Mendes F; Gano L; Campello MP; Bodio E
    ChemMedChem; 2014 Jul; 9(7):1567-73. PubMed ID: 24449620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro anticancer activities and optical imaging of novel intercalative non-cisplatin conjugates.
    Gao J; Woolley FR; Zingaro RA
    J Med Chem; 2005 Nov; 48(23):7192-7. PubMed ID: 16279777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical comparison in AR4-2J tumor-bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-somatostatin analogs for tumor diagnosis and internal radiotherapy.
    Froidevaux S; Heppeler A; Eberle AN; Meier AM; Häusler M; Beglinger C; Béhé M; Powell P; Mäcke HR
    Endocrinology; 2000 Sep; 141(9):3304-12. PubMed ID: 10965902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective targeting of E. coli heat-stable enterotoxin analogs to human colon cancer cells.
    Giblin MF; Sieckman GL; Watkinson LD; Daibes-Figueroa S; Hoffman TJ; Forte LR; Volkert WA
    Anticancer Res; 2006; 26(5A):3243-51. PubMed ID: 17094436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.
    Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X
    J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DOTA]Somatostatin-14 analogs and their (111)In-radioligands: effects of decreasing ring-size on sst1-5 profile, stability and tumor targeting.
    Tatsi A; Maina T; Cescato R; Waser B; Krenning EP; de Jong M; Cordopatis P; Reubi JC; Nock BA
    Eur J Med Chem; 2014 Feb; 73():30-7. PubMed ID: 24378707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.